Regarding the other cancer-associated genes, the cancer panel and exome detected six incidental variants in five patients (10%), in four different genes: one pathogenic and one likely pathogenic variant in CHEK2, two pathogenic variants in MUTYH, and one each in MSH2 and WRN (Table 5). This evidence concerns the gene CHEK2 and cancer.